Acetazolamide is a sulfonamide-derivative carbonic anhydrase inhibitor used to manage glaucoma, altitude sickness, certain epileptic syndromes and fluid-retention conditions by reducing bicarbonate and fluid formation across multiple tissues. Simson Pharma's Acetazolamide reference standard and impurities support compendial assay and stability-indicating method work across this diverse range of indications.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Acetazolamide Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.
